Advertisement
Loading...

Inotiv, Inc.

NOTVNASDAQ
Healthcare
Medical - Diagnostics & Research
$0.29
$-0.02(-5.89%)
U.S. Market opens in 37h 17m

Inotiv, Inc. Fundamental Analysis

Inotiv, Inc. (NOTV) shows moderate financial fundamentals with a PE ratio of -0.12, profit margin of -17.14%, and ROE of -74.67%. The company generates $0.5B in annual revenue with moderate year-over-year growth of 4.54%.

Key Strengths

Cash Position150.54%
PEG Ratio-0.01

Areas of Concern

ROE-74.67%
Operating Margin-8.87%
Current Ratio0.27
We analyze NOTV's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -82.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-82.2/100

We analyze NOTV's fundamental strength across five key dimensions:

Efficiency Score

Weak

NOTV struggles to generate sufficient returns from assets.

ROA > 10%
-12.38%

Valuation Score

Excellent

NOTV trades at attractive valuation levels.

PE < 25
-0.12
PEG Ratio < 2
-0.01

Growth Score

Moderate

NOTV shows steady but slowing expansion.

Revenue Growth > 5%
4.54%
EPS Growth > 10%
49.64%

Financial Health Score

Weak

NOTV carries high financial risk with limited liquidity.

Debt/Equity < 1
5.41
Current Ratio > 1
0.27

Profitability Score

Weak

NOTV struggles to sustain strong margins.

ROE > 15%
-7466.60%
Net Margin ≥ 15%
-17.14%
Positive Free Cash Flow
No

Key Financial Metrics

Is NOTV Expensive or Cheap?

P/E Ratio

NOTV trades at -0.12 times earnings. This suggests potential undervaluation.

-0.12

PEG Ratio

When adjusting for growth, NOTV's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values Inotiv, Inc. at 0.13 times its book value. This may indicate undervaluation.

0.13

EV/EBITDA

Enterprise value stands at -38.38 times EBITDA. This is generally considered low.

-38.38

How Well Does NOTV Make Money?

Net Profit Margin

For every $100 in sales, Inotiv, Inc. keeps $-17.14 as profit after all expenses.

-17.14%

Operating Margin

Core operations generate -8.87 in profit for every $100 in revenue, before interest and taxes.

-8.87%

ROE

Management delivers $-74.67 in profit for every $100 of shareholder equity.

-74.67%

ROA

Inotiv, Inc. generates $-12.38 in profit for every $100 in assets, demonstrating efficient asset deployment.

-12.38%

Following the Money - Real Cash Generation

Operating Cash Flow

Inotiv, Inc. generates limited operating cash flow of $356.40K, signaling weaker underlying cash strength.

$356.40K

Free Cash Flow

Inotiv, Inc. generates weak or negative free cash flow of $-13.70M, restricting financial flexibility.

$-13.70M

FCF Per Share

Each share generates $-0.39 in free cash annually.

$-0.39

FCF Yield

NOTV converts -1.35% of its market value into free cash.

-1.35%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.12

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.13

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.02

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

5.41

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.27

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.75

vs 25 benchmark

ROA

Return on assets percentage

-0.12

vs 25 benchmark

ROCE

Return on capital employed

-0.28

vs 25 benchmark

How NOTV Stacks Against Its Sector Peers

MetricNOTV ValueSector AveragePerformance
P/E Ratio-0.1228.62 Better (Cheaper)
ROE-74.67%783.00% Weak
Net Margin-17.14%-48181.00% (disorted) Weak
Debt/Equity5.410.39 Weak (High Leverage)
Current Ratio0.274.12 Weak Liquidity
ROA-12.38%-21914.00% (disorted) Weak

NOTV outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Inotiv, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

183.68%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-389.78%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-371.00%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ